Sensenbrenner syndrome

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC

Sensenbrenner syndrome
Scaphocephaly anteroposterior
Synonyms	Cranioectodermal dysplasia
Pronounce
Specialty	Medical genetics
Symptoms	Craniosynostosis, ectodermal dysplasia, skeletal dysplasia, renal disease, hepatic fibrosis
Complications	N/A
Onset	Infancy
Duration	Lifelong
Types	N/A
Causes	Genetic mutation
Risks
Diagnosis	Genetic testing, clinical evaluation
Differential diagnosis	Jeune syndrome, Ellis-van Creveld syndrome
Prevention	N/A
Treatment	Symptomatic treatment, supportive care
Medication
Prognosis	Variable, depends on severity of symptoms
Frequency	Rare
Deaths

Sensenbrenner Syndrome, also known as Cranioectodermal Dysplasia, is a rare genetic disorder characterized by a spectrum of abnormalities affecting multiple systems of the body. This condition is part of a group of diseases known as ciliopathies, which are caused by dysfunction of cilia, microscopic hair-like structures that extend from the surface of almost all cell types in the body. Sensenbrenner Syndrome is inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected.

Symptoms and Characteristics

Sensenbrenner Syndrome presents with a wide range of symptoms and physical characteristics, which can vary significantly among affected individuals. Common features include:

• Craniofacial abnormalities, such as a narrow, elongated head (dolichocephaly), prominent forehead, and low-set ears.
• Skeletal dysplasia, leading to short stature and abnormalities in the fingers and toes (such as polydactyly or syndactyly).
• Ectodermal dysplasia, affecting the skin, hair, and nails. Individuals may have sparse hair, abnormal nail growth, and sensitive skin.
• Kidney abnormalities, which can range from mild to severe and may affect kidney function.
• Liver dysfunction and abnormalities in other internal organs.
• Vision problems, including retinitis pigmentosa, which can lead to vision loss.

Genetics

The genetic mutations responsible for Sensenbrenner Syndrome have been identified in several genes, all of which are important for the proper formation and function of cilia. These genes include IFT122, WDR35, IFT43, and others. The mutations disrupt the normal development and function of cilia, leading to the wide range of symptoms seen in the syndrome.

Diagnosis

Diagnosis of Sensenbrenner Syndrome is based on a combination of clinical evaluation, family history, and genetic testing. Imaging studies, such as X-rays and MRI, may be used to assess skeletal abnormalities, while kidney and liver function tests can help evaluate organ involvement. Genetic testing can confirm the diagnosis by identifying mutations in the genes associated with the condition.

Treatment

There is no cure for Sensenbrenner Syndrome, and treatment focuses on managing symptoms and improving quality of life. This may include:

• Orthopedic interventions for skeletal abnormalities.
• Dermatological care for skin, hair, and nail issues.
• Regular monitoring and treatment of kidney and liver function.
• Vision care, including corrective lenses and management of retinitis pigmentosa.
• Supportive therapies, such as physical therapy and occupational therapy, to enhance mobility and daily functioning.

Prognosis

The prognosis for individuals with Sensenbrenner Syndrome varies depending on the severity of symptoms and the extent of organ involvement. Early diagnosis and comprehensive management of symptoms can improve the quality of life and lifespan of affected individuals.